| 9.30am |
Registration and Coffee |
| 10.00am |
An Introduction to MSD: Exploring Immunoassay Technology across the Translational Continuum
Pankaj Oberoi, Executive Vice President of Proteomics Technology, MSD |
| 10.20am |
Measure What Others Miss: Ultrasensitive Protein Detection with S-PLEX
Mark Duerr, Senior Manager, Field Application Support, MSD |
| 10.50am |
Reading Infection Histories from Antibodies: Longitudinal Serology from SARS-CoV-2 to Enteroviruses
Dr. Katharina Röltgen, Scientific Group Leader, Viral Immunology, Swiss TPH |
| 11.20am |
Coffee Break |
| 11.40am |
An Introduction to ProteinXI: High Multiplex Assays with Absolute Quantitation at Scale
Anne-Sophie Thomas-Claudepierre, Senior Director Sales, ProteinXI |
| 12.00pm |
Large-Scale Targeted Proteomics for Deep Phenotyping of Human Rheumatic Diseases: A Cross-Platform Comparison
Ana Kitanovic, PhD, Head of Robotics Facility, Deutsches Rheuma-Forschungszentrum Berlin (DRFZ) |
| 12.30pm |
Building Robust Assays: Best Practices for Reliable, Reproducible Results
Natacha Vanattou, Field Application Scientist, MSD |
| 12.50pm |
MSD-SET for the Characterisation of High-Affinity Antibodies
Alessandro Sinopoli, Principal Scientist, Ridgeline Discovery |
| 1.20pm |
Networking Lunch |
| 2.00pm |
Meeting Close |
